Abstract
The Authors, after introducing the epidemiology and physiopathology of medullary thyroid carcinoma, compare the most recent diagnostic methods and therapeutic strategies. They highlight recent progress in genetics, in diagnosis and therapy and in the role of labelled radiopharmaceuticals in diagnosis, post-operative therapy and follow-up.
MeSH terms
-
3-Iodobenzylguanidine
-
Adult
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Calcitonin / blood
-
Carcinoembryonic Antigen / analysis
-
Carcinoma, Medullary* / diagnosis
-
Carcinoma, Medullary* / therapy
-
Child
-
Combined Modality Therapy
-
Female
-
Humans
-
Immunohistochemistry
-
Iodine Radioisotopes / therapeutic use
-
Iodobenzenes / therapeutic use
-
Lymph Node Excision
-
Lymphatic Metastasis
-
Male
-
Middle Aged
-
Parathyroid Hormone / blood
-
Prognosis
-
Thyroid Neoplasms* / diagnosis
-
Thyroid Neoplasms* / therapy
-
Thyroidectomy
Substances
-
Antineoplastic Agents
-
Carcinoembryonic Antigen
-
Iodine Radioisotopes
-
Iodobenzenes
-
Parathyroid Hormone
-
3-Iodobenzylguanidine
-
Calcitonin